CP has also shown efficacy against psoriasis, an inflammatory skin condition with abnormal keratinocyte activity that exhibit aberrant MAPK, PI3K/Akt, STAT3, and NFκB pathway [282]. This evidence concerns the gene NFKB1 and psoriasis.